$2.26
+0.04 (+1.80%)
OVID News4 articles
Pfizer Shares Dip as GSK RSV Vaccine Gains Ground, Eliquis Data Provides Support
Pfizer shares declined 1% to $26.60 Friday after GSK secured expanded FDA approval for its RSV vaccine, challenging Pfizer's market position. Encouraging clinical results for blood thinner Eliquis helped cushion the drop.
Apple Shares Slide Amid Tech Rout, India Production Hopes Provide Cushion
Apple shares declined nearly 2% to $255.76, trimming its market cap to approximately $4.05 trillion. The drop coincided with a broader tech sell-off driven by oil price spikes and the launch of new, more affordable Apple devices.
Bitcoin Retreats as Oil Spike Fuels Inflation Fears, ETF Inflows Provide Support
Bitcoin declined over 1% as escalating Middle East tensions drove oil prices higher, stoking inflation concerns. However, U.S. spot Bitcoin ETFs recorded significant inflows, highlighting conflicting market forces.
Nvidia Shares Dip as Market Awaits Earnings, Meta Deal Provides Support
Nvidia shares declined 0.7% to $186.69 in Thursday trading, giving back some of Wednesday's gains. The pullback comes ahead of next week's quarterly earnings report and amid broader semiconductor sector weakness.